Hikma Seeks Rehearing In Vascepa Skinny-Label Case
Claims Panel Decision To Reopen Case Contradicts Precedent And Will Chill Competition
Hikma has asked the US Court of Appeals for the Federal Circuit for a full court rehearing of a panel decision that earlier this year reopened a dispute with Amarin over a skinny-label generic version of Vascepa.
